SENSIDX
DEAD

Serial Number

76408266

Owner

Ambri Ltd.

Attorney

Julie A. Katz

Filing Date

May 13, 2002

Add to watchlist:

No watchlists yet
View on USPTO

SENSIDX Trademark

Serial Number: 76408266 • Registration: 2892418

SENSIDX is a trademark filed by Ambri Ltd. on May 13, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Ambri Ltd. (4 trademarks)

126 Greville St.
Chatswood, NSW 2067 , AU

Entity Type: 11

Trademark Details

Filing Date

May 13, 2002

Registration Date

October 12, 2004

Published for Opposition

May 11, 2004

Cancellation Date

May 13, 2011

Goods & Services

Educational services, namely, conducting classes, workshops and seminars in the field of scientific research; museum services

Biosensors, detectors, electric-dynamic apparatus for the remote control of signals, indicators, measuring apparatus and instruments for use in scientific research namely, non-medical analysis, biomedical test systems comprised primarily of reading and analyzing instruments for use in scientific; research namely, non-medical analysis including environmental, food and water analysis, cassettes or cartridges having membrane based reaction regimes designated to react with or test for particular biological and chemical components and analytes

Pharmaceutical preparations for the diagnosis and treatment of blood diseases, electrolytes, cardiac markers, infectious diseases, immune deficiencies, whole blood glucose, drugs of abuse, urinalysis, coagulation and hemoglobin/hematocrit, and bioterrorism diseases; medical diagnostic reagents; diagnostic reagents for clinical and medical laboratory use

Chemical reagents for scientific use

Medical and veterinarian services, medical and veterinary diagnostic services

Biosensors, detectors, electro-dynamic apparatus for the remote control of signals, indicators, measuring apparatus and instruments for use in medical and clinical diagnostics namely clinical diagnostic markers and cardiac markers; biomedical test systems, comprised primarily of reading and analyzing instruments for use in the diagnosis and treatment of blood diseases, electrolytes, cardiac markers, infectious diseases, immune deficiencies, whole blood glucose, drugs of abuse, urinalysis, coagulation and hemoglobin/hematocrit, and bioterrorism diseases; diagnostic test cassettes or cartridges having membrane based reaction regimes designated to react with or test for particular biological and chemical components and analytes

Scientific, environmental, food, water and educational research and development services for others, namely, biological, chemical, biochemical, molecular, genetic based research and diagnostic services; scientific research services; medical and veterinary analysis services in the nature of biological, chemical, biochemical, molecular, genetic-based research services

Filing History

CANCELLED SEC. 8 (6-YR)
May 13, 2011 C8..
REGISTERED-PRINCIPAL REGISTER
Oct 12, 2004 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 18, 2004 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 9, 2004 ETOF
PUBLISHED FOR OPPOSITION
May 11, 2004 PUBO
NOTICE OF PUBLICATION
Apr 21, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2004 CNSA
CASE FILE IN TICRS
Nov 20, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2003 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2003 TROA
NON-FINAL ACTION MAILED
May 6, 2003 CNRT
FINAL REFUSAL MAILED
Mar 7, 2003 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 2, 2003 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2002 CRFA
PAPER RECEIVED
Dec 18, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2002 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2002 TROA
NON-FINAL ACTION MAILED
Sep 30, 2002 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2002 DOCK
PAPER RECEIVED
Aug 12, 2002 MAIL
PAPER RECEIVED
Jul 5, 2002 MAIL